145 related articles for article (PubMed ID: 35591845)
1. Phosphotyrosine picked threonine kinase stimulates proliferation of human osteosarcoma cells
Wang ZX; Ren SC; Ren J
Arch Med Sci; 2022; 18(3):775-785. PubMed ID: 35591845
[TBL] [Abstract][Full Text] [Related]
2. TTK contributes to tumor growth and metastasis of clear cell renal cell carcinoma by inducing cell proliferation and invasion.
Liu XD; Yao DW; Xin F
Neoplasma; 2019 Nov; 66(6):946-953. PubMed ID: 31607131
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract][Full Text] [Related]
4. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
Wang ZX; Ren SC; Chang ZS; Ren J
Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
[TBL] [Abstract][Full Text] [Related]
5. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
6. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
[TBL] [Abstract][Full Text] [Related]
7. IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression.
Schmandt R; Hill M; Amendola A; Mills GB; Hogg D
J Immunol; 1994 Jan; 152(1):96-105. PubMed ID: 8254211
[TBL] [Abstract][Full Text] [Related]
8. Expression of TTK, a novel human protein kinase, is associated with cell proliferation.
Mills GB; Schmandt R; McGill M; Amendola A; Hill M; Jacobs K; May C; Rodricks AM; Campbell S; Hogg D
J Biol Chem; 1992 Aug; 267(22):16000-6. PubMed ID: 1639825
[TBL] [Abstract][Full Text] [Related]
9. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
[TBL] [Abstract][Full Text] [Related]
10. High tyrosine threonine kinase expression predicts a poor prognosis: a potential therapeutic target for endometrial carcinoma.
Cui CH; Wu Q; Zhou HM; He H; Wang Y; Tang Z; Zhang Y; Wang X; Xiao J; Zhang H
Ann Transl Med; 2022 Dec; 10(24):1352. PubMed ID: 36660721
[TBL] [Abstract][Full Text] [Related]
11. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
12. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
[TBL] [Abstract][Full Text] [Related]
13. Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway.
Ren C; Pan R; Hou L; Wu H; Sun J; Zhang W; Tian X; Chen H
Mol Med Rep; 2020 Apr; 21(4):1739-1748. PubMed ID: 32319617
[TBL] [Abstract][Full Text] [Related]
14. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.
Gao S; Wang J; Tian S; Luo J
Int J Oncol; 2019 Jun; 54(6):1921-1932. PubMed ID: 31081054
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
16. Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer.
Miao R; Wu Y; Zhang H; Zhou H; Sun X; Csizmadia E; He L; Zhao Y; Jiang C; Miksad RA; Ghaziani T; Robson SC; Zhao H
Sci Rep; 2016 Sep; 6():33121. PubMed ID: 27618777
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
Maia AR; de Man J; Boon U; Janssen A; Song JY; Omerzu M; Sterrenburg JG; Prinsen MB; Willemsen-Seegers N; de Roos JA; van Doornmalen AM; Uitdehaag JC; Kops GJ; Jonkers J; Buijsman RC; Zaman GJ; Medema RH
Ann Oncol; 2015 Oct; 26(10):2180-92. PubMed ID: 26153498
[TBL] [Abstract][Full Text] [Related]
18. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment.
Wang ZX; Guo MY; Ren J; Li GS; Sun XG
Orthop Surg; 2020 Aug; 12(4):1253-1260. PubMed ID: 32558212
[TBL] [Abstract][Full Text] [Related]
19. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
Gao YH; Qu SS; Cao LQ; Yao M
Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
[TBL] [Abstract][Full Text] [Related]
20. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
